Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Clinical trial NCT00112879 · WITHDRAWN

Trial details

NCT number: NCT00112879
Sponsor: The Cleveland Clinic
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Refractory Plasma Cell Neoplasm

Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.